The FDA granted orphan drug designation to CYNK-101, an investigational natural killer cell-based therapy for treatment of advanced HER2/neu-positive gastric…
Browsing: Hot headlines in GI
Dr. Abreu is in line to be president-elect in 2023, then president of the 16,000-member AGA in ’24. “I have…
Scottsdale, Ariz.-based North Valley Surgery Center is kicking off a colon cancer screening program for women, the ASC’s joint venture partner Sovereign…
The new data comes from the 1,162-subject LUCENT-1 trial – first unveiled last year – which compared induction treatment with the anti-IL-23p19…
In this issue of “Endoscopy Insights,” I’m focusing on resection of colon polyps, an essential tool in the gastroenterologist’s toolbox…
The emerging treatment landscape of nonalcoholic steatohepatitis has “exploded” as understanding of the pathogenesis grows, according to a presenter at GUILD 2022.…
The digestive system’s main job might be to break down food and keep us nourished, but that’s not all the…
Crohn’s disease is a type of inflammatory bowel disease that affects the lining of the digestive tract. Symptoms can include…
People with nonalcoholic fatty liver disease cirrhosis fare worse before and after liver transplant surgery if they are not overweight…
The FDA extended its review period for risankizumab (Skyrizi) for a proposed indication in Crohn’s disease by 3 months, in…